Kühn H, Chan L
Institute of Biochemistry, University Clinics Charité, Humboldt University, Berlin, Germany.
Curr Opin Lipidol. 1997 Apr;8(2):111-7. doi: 10.1097/00041433-199704000-00009.
Oxidative modification converts LDL to an atherogenic form and 15-lipoxygenase has been implicated in this process. Several lines of experimental evidence support such a proatherogenic action of the enzyme. However, recent data obtained with transgenic rabbits overexpressing 15-lipoxygenase suggest also an antiatherogenic effect. In this paper the pathophysiological relevance of 15-lipoxygenase in atherogenesis is critically reviewed.